Comparing Actemra vs Canakinumab
| Actemra (tocilizumab) | Canakinumab |
|
|---|
| Actemra (tocilizumab) | Canakinumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Giant Cell Arteritis, Rheumatoid Arthritis, COVID-19, Cytokine Release Syndrome, Polyarticular Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis, Systemic... View more |
Prescription only
Prescribed for Familial Mediterranean Fever, Familial Cold Autoinflammatory Syndrome, Cryopyrin-Associated Periodic Syndromes, Gout - Acute, Hyperimmunoglobulin D Syndrome, Juvenile Idiopathic... View more |
Related suggestions Juvenile Idiopathic Arthritis
Popular comparisons
|
|||||||
| More about Actemra (tocilizumab) | More about Canakinumab | ||||||||
| Ratings & Reviews | |||||||||
|
Actemra has an average rating of 6.7 out of 10 from a total of 49 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 24% reported a negative effect. |
Canakinumab has an average rating of 10.0 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Actemra side effects |
View all Canakinumab side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Actemra prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other tocilizumab brands include: Avtozma, Tofidence, Tyenne | Ilaris | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
210 hours |
624 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 427 drugs are known to interact with Actemra:
|
A total of 514 drugs are known to interact with Canakinumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 08, 2010 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.